HomeComparePBIGF vs SBUX

PBIGF vs SBUX: Dividend Comparison 2026

PBIGF yields 1111.11% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PBIGF wins by $47499205.92M in total portfolio value
10 years
PBIGF
PBIGF
● Live price
1111.11%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47499206.07M
Annual income
$40,354,669,257,990.61
Full PBIGF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — PBIGF vs SBUX

📍 PBIGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBIGFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBIGF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBIGF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBIGF
Annual income on $10K today (after 15% tax)
$94,444.44/yr
After 10yr DRIP, annual income (after tax)
$34,301,468,869,292.02/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, PBIGF beats the other by $34,301,468,813,327.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBIGF + SBUX for your $10,000?

PBIGF: 50%SBUX: 50%
100% SBUX50/50100% PBIGF
Portfolio after 10yr
$23749603.12M
Annual income
$20,177,334,661,915.37/yr
Blended yield
84.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

PBIGF
No analyst data
Altman Z
-20.2
Piotroski
2/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBIGF buys
0
SBUX buys
6
PoliticianChamberTickerTypeAmountDate
Shelley Moore Capito🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-28
Shelley Moore Capito🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-28
Sheldon Whitehouse🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-09
Sheldon Whitehouse🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-09
Sheldon Whitehouse🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-09
Sheldon Whitehouse🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-09
Dan Newhouse🏢 House$SBUX▼ Sell$1,001 - $15,0002025-12-11
Ro Khanna🏢 House$SBUX▼ Sell$15,001 - $50,0002025-10-07
Ro Khanna🏢 House$SBUX▲ Buy$15,001 - $50,0002025-09-29
Ro Khanna🏢 House$SBUX▼ Sell$15,001 - $50,0002025-08-26
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBIGFSBUX
Forward yield1111.11%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$47499206.07M$157.5K
Annual income after 10y$40,354,669,257,990.61$65,840.13
Total dividends collected$46960998.57M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: PBIGF vs SBUX ($10,000, DRIP)

YearPBIGF PortfolioPBIGF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$121,811$111,111.11$11,107$407.21+$110.7KPBIGF
2$1,395,251$1,264,912.89$12,512$626.87+$1.38MPBIGF
3$15,033,652$13,540,734.05$14,366$978.69+$15.02MPBIGF
4$152,440,880$136,354,872.42$16,929$1,557.50+$152.42MPBIGF
5$1,455,294,162$1,292,182,420.27$20,658$2,543.80+$1455.27MPBIGF
6$13,086,105,030$11,528,940,276.13$26,406$4,302.22+$13086.08MPBIGF
7$110,889,069,345$96,886,936,963.27$35,877$7,622.00+$110889.03MPBIGF
8$885,941,741,006$767,290,436,806.24$52,741$14,352.64+$885941.69MPBIGF
9$6,677,137,211,537$5,729,179,548,660.89$85,676$29,243.03+$6677137.13MPBIGF
10$47,499,206,074,335$40,354,669,257,990.61$157,513$65,840.13+$47499205.92MPBIGF

PBIGF vs SBUX: Complete Analysis 2026

PBIGFStock

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

Full PBIGF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this PBIGF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBIGF vs SCHDPBIGF vs JEPIPBIGF vs OPBIGF vs KOPBIGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.